
Omicron: Pfizer-BioNTech COVID-19 vaccine may only partially protect against new variant, study suggests
Fox News
A new study led by the Africa Health Research Institute reportedly suggests that the omicron COVID-19 variant escapes antibody immunity induced by two doses of the Pfizer-BioNTech vaccine.
Six of the participants had no previous record of SARS-CoV-2 infection nor detectable nucleocapsid antibodies indicative of previous infection.
There was an observed 41-fold decline in vaccine-induced neutralizing antibodies compared to the ancestral strain of the virus, the researchers said.
More Related News

Colorado school district in the hot seat for allegedly factoring in race for disciplinary procedures
A civil rights complaint is accusing a Colorado school district of factoring race into student discipline, giving different punishments for the same infractions.












